Literature DB >> 16972229

Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.

Dirk Roos1, Martin de Boer, M Yavuz Köker, Jan Dekker, Vinita Singh-Gupta, Anders Ahlin, Jan Palmblad, Ozden Sanal, Magdalena Kurenko-Deptuch, Stephen Jolles, Baruch Wolach.   

Abstract

Chronic granulomatous disease (CGD) is an inherited immunodeficiency caused by defects in any of four genes encoding components of the leukocyte nicotinamide dinucleotide phosphate, reduced (NADPH) oxidase. One of these is the autosomal neutrophil cytosolic factor 1 (NCF1) gene encoding the p47phox protein. Most (>97%) CGD patients without p47phox (A47 degrees CGD) are homozygotes for one particular mutation in NCF1, a GT deletion in exon 2. This is due to recombination events between NCF1 and its two pseudogenes (psiNCF1) that contain this GT deletion. We have previously set up a gene-scan method to establish the ratio of NCF1 genes and pseudogenes. With this method we now found, in three CGD families patients with the normal number of two intact NCF1 genes (and four psiNCF1 genes) and in six CGD families, patients with one intact NCF1 gene (and five psiNCF1 genes). All patients lacked p47phox protein expression. These results indicate that other mutations were present in their NCF1 gene than the GT deletion. To identify these mutations, we designed PCR primers to specifically amplify the cDNA or parts of the genomic DNA from NCF1 but not from the psiNCF1 genes. We found point mutations in NCF1 in eight families. In another family, we found a 2,860-bp deletion starting in intron 2 and ending in intron 5. In six families the patients were compound heterozygotes for the GT deletion and one of these other mutations; in two families the patients had a homozygous missense mutation; and in one family the patient was a compound heterozygote for a splice defect and a nonsense mutation. Family members with either the GT deletion or one of these other mutations were identified as carriers. This knowledge was used in one of the families for prenatal diagnosis. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972229     DOI: 10.1002/humu.20413

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

Review 1.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.

Authors:  Manasi Kulkarni; Gouri Hule; Martin de Boer; Karin van Leeuwen; Priyanka Kambli; Jahnavi Aluri; Maya Gupta; Aparna Dalvi; Snehal Mhatre; Prasad Taur; Mukesh Desai; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2018-11-23       Impact factor: 8.317

3.  Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Authors:  Harry R Hill; Nancy H Augustine; Robert J Pryor; Gudrun H Reed; Joshua D Bagnato; Anne E Tebo; Jeffrey M Bender; Brian M Pasi; Javier Chinen; I Celine Hanson; Martin de Boer; Dirk Roos; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

4.  Molecular basis of autosomal recessive chronic granulomatous disease in iran.

Authors:  Shahram Teimourian; Martin de Boer; Dirk Roos
Journal:  J Clin Immunol       Date:  2010-04-21       Impact factor: 8.317

5.  Clinical application of whole-genome sequencing in patients with primary immunodeficiency.

Authors:  Talal Mousallem; Thomas J Urban; K Melodi McSweeney; Sarah E Kleinstein; Mingfu Zhu; Mehdi Adeli; Roberta E Parrott; Joseph L Roberts; Brian Krueger; Rebecca H Buckley; David B Goldstein
Journal:  J Allergy Clin Immunol       Date:  2015-05-14       Impact factor: 10.793

6.  Clinical, Immunological, and Molecular Findings of Patients with p47phox Defect Chronic Granulomatous Disease (CGD) in Indian Families.

Authors:  Manasi Kulkarni; Mukesh Desai; Maya Gupta; Aparna Dalvi; Prasad Taur; Antony Terrance; Sunil Bhat; Mamta Manglani; Revathi Raj; Ira Shah; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

7.  Atypical presentation of chronic granulomatous disease in an adolescent boy with frontal lobe located Aspergillus abscess mimicking intracranial tumor.

Authors:  Turkan Patiroglu; Ekrem Unal; Ali Yikilmaz; M Yavuz Koker; Mustafa K Ozturk
Journal:  Childs Nerv Syst       Date:  2009-10-27       Impact factor: 1.475

8.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

9.  Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.

Authors:  Rabab El Hawary; Safa Meshaal; Caroline Deswarte; Nermeen Galal; Mahitab Abdelkawy; Radwa Alkady; Dalia Abd Elaziz; Tomas Freiberger; Barbora Ravcukova; Jiri Litzman; Jacinta Bustamante; Jeannette Boutros; Taghrid Gaafar; Aisha Elmarsafy
Journal:  J Clin Immunol       Date:  2016-05-24       Impact factor: 8.317

Review 10.  Homing endonucleases: from basics to therapeutic applications.

Authors:  Maria J Marcaida; Inés G Muñoz; Francisco J Blanco; Jesús Prieto; Guillermo Montoya
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.